ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Qingbing Wang
Matched on ORCID iD 0009-0006-2930-3875; OpenAlex author ID A5116568574. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper
Papers 7
- Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment. First author DOI 10.1002/smll.202107712↗
- OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngen… Co-author PMID 34249428↗
- Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.apsb.2019.11.013↗
- Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy. Co-author DOI 10.1039/d0tb00017e↗
- An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Co-author DOI 10.1073/pnas.1914557116↗
- KDM4B promotes epithelial-mesenchymal transition through up-regulation of ZEB1 in pancreatic cancer. Co-author DOI 10.1093/abbs/gmv107↗
- Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancer. First author DOI 10.2147/ijn.s84930↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaoyi Ding · 3 shared papers, 2020–2021 · strength 0.37
- Paper OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives system… PMID 34249428↗
- Paper Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy. DOI 10.1039/d0tb00017e↗
- Paper Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. DOI 10.1016/j.apsb.2019.11.013↗
- Tao Sun · 2 shared papers, 2020–2022 · strength 0.26
- Chen Jiang · 2 shared papers, 2020–2022 · strength 0.26
- Yu Zhou · 2 shared papers, 2020–2021 · strength 0.26
- Qinjun Chen · 2 shared papers, 2020–2022 · strength 0.25
- Chen Jiang · 2 shared papers, 2015–2020 · strength 0.17
- Paper Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. DOI 10.1016/j.apsb.2019.11.013↗
- Paper Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic can… DOI 10.2147/ijn.s84930↗
- Qiwei Zhang · 1 shared paper, 2021 · strength 0.15
- Yu Wang · 1 shared paper, 2022 · strength 0.15
- Yifan Luo · 1 shared paper, 2022 · strength 0.15
- Zhongmin Wang · 1 shared paper, 2020 · strength 0.11
- Fuyou Li · 1 shared paper, 2020 · strength 0.11
- Wei Huang · 1 shared paper, 2020 · strength 0.11
- Wenxi Zhou · 1 shared paper, 2020 · strength 0.11
- Xinli Chen · 1 shared paper, 2020 · strength 0.11
- Shuo Li · 1 shared paper, 2015 · strength 0.06
- Xiaolin Wang · 1 shared paper, 2015 · strength 0.06
- Yingyi Li · 1 shared paper, 2015 · strength 0.06
- Xiaomei Tang · 1 shared paper, 2019 · strength 0.06
- Xiongxiong Lu · 1 shared paper, 2019 · strength 0.06
- Yuan Fang · 1 shared paper, 2019 · strength 0.06
- Qian Zhan · 1 shared paper, 2019 · strength 0.06
- Min Li · 1 shared paper, 2019 · strength 0.06
- Chenghong Peng · 1 shared paper, 2019 · strength 0.06
- Lu Zhou · 1 shared paper, 2019 · strength 0.06
- Chenlei Wen · 1 shared paper, 2019 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.